Back to Agenda

Incorporating Longevity Medicine to Complement the Aesthetic Practice Clinical 2

More than 50% of the U.S. population is approaching their early 40s; as we age, so do the endocrine glands that manufacture our hormones. Not only do our hormone levels decline, but the tissues that respond to these hormones also become less sensitive. This results in decreased cellular repair, lower cell reproduction, a decline in cell turnover, reduced cellular function and less protein synthesis. Longevity medicine is fast on the rise, and patients seek providers who know how to address the changes in their skin, body and hormones. This presentation is focused on the fundamentals in longevity medicine needed to complement your already established aesthetic practice.